A detailed history of Ever Source Wealth Advisors, LLC transactions in Organon & Co. stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 3,738 shares of OGN stock, worth $55,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,738
Previous 5,204 28.17%
Holding current value
$55,210
Previous $107,000 33.64%
% of portfolio
0.0%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$18.65 - $23.03 $27,340 - $33,761
-1,466 Reduced 28.17%
3,738 $71,000
Q2 2024

Aug 13, 2024

BUY
$17.45 - $21.96 $3,036 - $3,821
174 Added 3.46%
5,204 $107,000
Q1 2024

Jun 11, 2024

BUY
$13.78 - $18.8 $9,770 - $13,329
709 Added 16.41%
5,030 $94,000
Q4 2023

Feb 09, 2024

BUY
$10.95 - $17.32 $22,721 - $35,939
2,075 Added 92.39%
4,321 $62,000
Q3 2023

Nov 03, 2023

BUY
$16.59 - $23.77 $18,414 - $26,384
1,110 Added 97.71%
2,246 $38,000
Q2 2023

Aug 04, 2023

BUY
$19.27 - $24.63 $1,079 - $1,379
56 Added 5.19%
1,136 $23,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $18,871 - $28,262
881 Added 442.71%
1,080 $25,000
Q4 2022

Feb 09, 2023

SELL
$23.31 - $28.61 $7,762 - $9,527
-333 Reduced 62.59%
199 $5,000
Q3 2022

Nov 07, 2022

BUY
$23.4 - $34.25 $8,845 - $12,946
378 Added 245.45%
532 $13,000
Q2 2022

Aug 01, 2022

SELL
$31.66 - $38.9 $601 - $739
-19 Reduced 10.98%
154 $6,000
Q1 2022

May 25, 2022

SELL
$30.45 - $39.36 $1,583 - $2,046
-52 Reduced 23.11%
173 $6,000
Q4 2021

Feb 07, 2022

BUY
$28.67 - $37.13 $6,450 - $8,354
225 New
225 $7,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.76B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.